April 9 (Reuters) - Grace Therapeutics, Inc GRCE.O:
GRACE THERAPEUTICS ANNOUNCES ALIGNMENT WITH THE FDA SUPPORTING THE PLANNED NDA SUBMISSION FOR GTX-104
GRACE THERAPEUTICS, INC: ANTICIPATES FILING ITS NDA FOR GTX-104 IN Q2 OF 2025
Source text: ID:nGNX5nQHtZ
Further company coverage: GRCE.O
((Reuters.Briefs@thomsonreuters.com;))